Back to Market返回行情

COCH Envoy Medical, Inc.

USHealthcare
$0.6937+1.86%OpenMarket Cap: $14.4M

As of 2026-07-10 14:19

Why COCH matters now

Envoy Medical, Inc. (COCH) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.69 with +1.86% on the session and $14.4M in market capitalization; recent performance reads 1-month -14.32% and YTD -4.10%.

The latest financial table shown here is Q1 2026, with revenue of $39.0K, net income of $-4.4M, and EPS of $-0.08. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -157.0%.

The latest indexable market news headline is "Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device" from Newsfile Corp.

Additional event context on this page matters because analyst consensus is Buy with a median target of $6.00; recent insider activity includes Lucas Brent T. filing A-Award. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

4.14

P/S

56.36

EV/EBITDA

0.52

DCF Value

$0.03

FCF Yield

-157.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

-310.7%

Operating Margin

-9881.2%

Net Margin

-9875.6%

ROE

239.4%

ROA

-77.5%

ROIC

-130.0%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$39.0K$-4.4M$-0.08
Q4 2025$75.0K$-6.6M$-0.27
FY 2025$241.0K$-23.8M$-1.23
Q3 2025$42.0K$-6.5M$-0.35

Analyst Ratings

Consensus

Buy

Target (Consensus)

$6.00

Target (Median)

$6.00

Target Range

$6.00 - $6.00

Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0

Trading Activity

Insider Trades

Lucas Brent T.director, officer: Chief Executive Officer
Sell2026-06-04
McKhann Chasdirector:
Sell2026-04-17
McKhann Chasdirector
Sell2026-04-17
TAYLOR GLEN A10 percent owner
Buy2026-02-17
TAYLOR GLEN A10 percent owner
Buy2026-02-17

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.89

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.